J Biomol Struct Dyn 34:21992213
Some individuals saw increases higher than that
What to monitor Track the following metrics to assess whether the levocarnitine addition is providing value: Body composition changes (use DEXA, InBody, or similar if accessible) Energy levels and exercise performance GI symptoms (compare to baseline on tirzepatide alone if possible) Liver function markers (ALT, AST) if baseline values were elevated General well-being and recovery quality If after 8 to 12 weeks the levocarnitine addition has not produced noticeable improvements in energy, exercise performance, or body composition compared to tirzepatide alone, consider adjusting your protocol or switching to a different compound blend
Bunyaratvej, A., Butthep, P., Sae-Ung, N., Fucharoen, S
Australian Pharmaceutical Benefits Scheme (PBS): In Australia, a large 10-year study found higher antidepressant use among people on GLP-1 drugs (34% vs 21%), though researchers could not prove a causal connection due to possible confounding factors
A regional supplier offers synchronized support hours for real-time stock checks, COA sharing, and proactive delivery updates, ensuring laboratory schedules are never disrupted
